Apiam Animal Health Limited

ASX:AHX.AX

0.41 (AUD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q2
Revenue 106.16100.292104.36498.03893.71981.91775.1464.95661.22562.13556.255.6756.0555.8250.77751.87546.11644.2769.82100
Cost of Revenue 81.70377.44185.87485.86377.08568.18862.89254.83850.70351.81347.15846.28646.82646.83442.33343.53838.0136.6139.41300
Gross Profit 24.45722.85118.4912.17516.63413.72912.24810.11810.52210.3229.0429.3849.2248.9868.4448.3378.1067.6630.40800
Gross Profit Ratio 0.230.2280.1770.1240.1770.1680.1630.1560.1720.1660.1610.1690.1650.1610.1660.1610.1760.1730.04200
Reseach & Development Expenses 00.2020.1980.2060.2040000000000000000
General & Administrative Expenses 000000000000000000000
Selling & Marketing Expenses 000000000000000000000
SG&A 0011.23711.1511.098.8687.5256.0256.3385.7815.8176.4680.9630.8560.6760.6590.6331.2280.22800
Other Expenses 0000.31800000000000000000
Operating Expenses 00.20211.23710.83211.098.8687.5256.0256.3385.7815.8176.4686.2266.2135.4575.3184.0713.9262.6360.4360.436
Operating Income 24.45722.6497.2531.3435.5444.8614.7234.0934.1844.5413.2252.9163.1483.113.1053.5373.0064.215-0.68-0.436-0.436
Operating Income Ratio 0.230.2260.0690.0140.0590.0590.0630.0630.0680.0730.0570.0520.0560.0560.0610.0680.0650.095-0.06900
Total Other Income Expenses Net -24.947-20.237-2.639-2.243-1.531-0.854-2.351-0.749-0.571-0.802-0.944-0.746-0.75-0.907-0.477-1.2020.616-1.423-0.0380.4360.436
Income Before Tax -0.492.4124.614-0.94.0134.0072.3723.3443.6133.7392.2812.172.3982.2032.6282.4433.6933.334-2.266-0.436-0.436
Income Before Tax Ratio -0.0050.0240.044-0.0090.0430.0490.0320.0510.0590.060.0410.0390.0430.0390.0520.0470.080.075-0.23100
Income Tax Expense 1.0040.7611.393-0.2251.221.2090.7220.9061.1341.1180.6560.6710.7480.7080.8370.6260.5851.2470.2720.0620.062
Net Income -1.5231.653.281-0.6212.8982.8891.752.5232.5592.4821.6891.5411.6241.5141.7641.8473.0552.052-2.002-0.374-0.374
Net Income Ratio -0.0140.0160.031-0.0060.0310.0350.0230.0390.0420.040.030.0280.0290.0270.0350.0360.0660.046-0.20400
EPS -0.0080.0090.018-0.0040.0170.0210.0130.020.0210.0210.0150.0140.0160.0120.0170.0180.030.021-0.1-0.004-0.004
EPS Diluted -0.0080.0090.018-0.0040.0170.0210.0130.020.0210.0210.0150.0140.0160.0150.0170.0180.0310.021-0.097-0.004-0.004
EBITDA 10.4259.13313.0776.75210.3629.2767.0327.1757.3187.5355.8044.6084.6494.4044.2434.4344.7124.719-0.5700
EBITDA Ratio 0.0980.0910.1250.0690.1110.1130.0940.110.120.1210.1030.0830.0830.0790.0840.0850.1020.107-0.05800